Five Prime Announces Third Quarter 2016 Results and Provides Business Update
Nov 03, 2016 20:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
Benefitfocus Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:05 pm UTC| Business
Total revenue of $58.0 million grew 28% year-over-yearEmployer revenue of $35.4 million grew 55% year-over-year CHARLESTON, S.C., Nov. 03, 2016 -- Benefitfocus, Inc. (NASDAQ:BNFT), a leading provider of cloud-based...
Varonis Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:05 pm UTC| Business
Total revenues of $40.9 million, up 31% year-over-yearLicense revenues of $22.6 million, up 34% year-over-year NEW YORK, Nov. 03, 2016 -- Varonis Systems, Inc. (Nasdaq:VRNS), a leading provider of software solutions...
Nov 03, 2016 20:05 pm UTC| Business
SAN DIEGO, Nov. 03, 2016 -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today...
Web.com Reports Third Quarter 2016 Financial Results
Nov 03, 2016 20:05 pm UTC| Business
Reduced debt by $23.0 millionGenerated $44.5 million in operating cash flow, up 26% year over yearAdded $100 million to stock repurchase authorization and extended to end of 2018 JACKSONVILLE, Fla., Nov. 03, 2016 --...
TrueCar Reports Third Quarter 2016 Financial Results
Nov 03, 2016 20:05 pm UTC| Business
Third quarter total revenue up 4% from a year ago to $75.1 million.Third quarter net loss of $(7.4) million, or $(0.09) per share, compared to net loss of $(11.1) million, or $(0.13) per share, in the third quarter of...
Nov 03, 2016 20:05 pm UTC| Business
SAN DIEGO, Nov. 03, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...